The significant reliance on forward-looking statements may create uncertainty about the company's future, as actual outcomes could differ materially from expectations due to various risks and ...
PeptiDream, PDRadiopharma and Curium Group Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan PeptiDream Inc., a public Kanagawa, Japan-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback